|
WO2020120133A1
|
|
Nanoelectronic device and method for producing thereof
|
|
EP3771463A1
|
|
Stabilizing therapeutic proteins with piperazin- or morpholine-containing zwitterionic buffering substances
|
|
EP3763356A1
|
|
Excipient for biotherapeutics
|
|
EP3747872A1
|
|
Carbocyclic nucleoside analogue
|
|
EP3689450A1
|
|
Method for producing a metal organic framework film, metal organic framework film and use of a metal organic framework film
|
|
DE102018010063A1
|
|
Preparation of Vesicular Phospholipid Gels by Screw Extrusion
|
|
EP3653608A1
|
|
Isoquinoline biaryl compounds, a pharmaceutical composition comprising the same, and uses thereof
|
|
EP3676750A1
|
|
Detection of biological cells and tracing of cell lineage
|
|
EP3498865A1
|
|
Single molecule detection or quantification by means of dna nanotechnology in micro-wells
|
|
LU100527B1
|
|
Ezetimibe and disulfiram for the treatment of cardiac diseases
|
|
LU100526B1
|
|
Ezetimibe and disulfiram for the treatment of cardiac diseases
|
|
EP3431484A1
|
|
A fluorescent cyclic dinucleotide and its use in methods of identifying substances having an ability to modulate the cgas/sting pathway
|
|
EP3472351A1
|
|
Single molecule detection or quantification using dna nanotechnology
|
|
EP3411496A1
|
|
Molecular identification with sub-nanometer localization accuracy
|
|
EP3330282A1
|
|
Cipa, cipb and pixa as scaffolds to organize proteins into crystalline inclusions
|
|
AU2016307064A1
|
|
Mesoporous calcium phosphate-citrate nanoparticles and uses thereof
|
|
AU2015340591A1
|
|
Means and methods for site-specific functionalization of polypeptides
|
|
EP3045181A1
|
|
A novel vaccine against the middle east respiratory syndrome coronavirus (MERS-CoV)
|
|
EP2866311A1
|
|
Method and device for controlling a carrier-envelope phase and/or an intensity of output pulses of a pulse laser device
|
|
EP2828613A1
|
|
Swept source oct system and method with phase-locked detection
|
